The Childhood Absence Epilepsy Treatment market is estimated to be valued at US$ 238.05 Mn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:
Childhood absence epilepsy is a common form of epilepsy seen in children between the ages of 4 to 12 years marked with brief and...